Lexeo Therapeutics

Lexeo Therapeutics is a clinical-stage genetic medicines company headquartered in New York City, dedicated to transforming healthcare by developing innovative gene therapies that target the underlying genetic cause of diseases. Their focus is on high-impact genetic medicine candidates for cardiovascular diseases and APOE4-associated Alzheimer's disease. Lexeo prioritizes efficient development, advanced manufacturing, and strategic partnerships to bring these therapies to patients as quickly and safely as possible.

Lexeo's commitment to patients is evident in their patient-centric approach, with a dedicated Patient & Community portal that provides resources and information for individuals living with genetic diseases. The company also actively engages with patient advocacy groups and collaborates with leading academic institutions to advance their research and clinical development programs. They believe that by targeting the root cause of these debilitating diseases, they can significantly improve the lives of patients and their families.

Lexeo Therapeutics offers a hybrid work model for most roles, allowing employees to split their time between working in the New York City office and working from home. While an in-office presence is required 5 days a week for the Executive Assistant role, remote work is considered for exceptional candidates in other positions, particularly those located across the Northeast and Mid-Atlantic.

Lexeo Therapeutics offers a comprehensive benefits package that covers health, wellness, retirement, and time off. They provide health, dental, and vision insurance, as well as flexible spending and health savings accounts. Additional benefits include disability and life insurance, mental health coverage, commuter benefits, a tech stipend, a stocked kitchen, in-office lunch stipends, a 401(k) with a company match, performance bonuses, company equity, unlimited paid time off, paid holidays, and paid parental leave.

Lexeo Therapeutics is a clinical-stage genetic medicines company focused on transforming healthcare by developing innovative gene therapies that target the root cause of devastating diseases. They prioritize conditions with high unmet needs and significant potential for societal impact, specifically focusing on genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease. Lexeo aims to create substantial positive impact by reducing the burdens placed on patients, caregivers, and healthcare systems.

Lexeo Therapeutics fosters a culture of innovation, collaboration, and ambition, driven by a shared passion for transforming healthcare through groundbreaking genetic medicines. They value a hybrid work model, promoting flexibility while encouraging teamwork and a collaborative spirit. The company prioritizes attracting and retaining passionate individuals who share their commitment to improving patient lives, evidenced by their emphasis on employee benefits, professional development, and a diverse and inclusive work environment.

Lexeo Therapeutics is committed to fostering a diverse, equitable, and inclusive work environment. They believe that a diverse workforce leads to better decision-making, innovation, and overall success. They are actively working to attract, retain, and develop talent from a variety of backgrounds and experiences. Lexeo is committed to providing equal opportunities for all employees and creating a workplace where everyone feels valued, respected, and empowered to contribute their unique skills and perspectives.